Author: administrator

Categories
Pharmaceutical

Small Molecule Segment Will Account For Largest Share In Folliculotropic Mycosis Fungoides Treatment Market

According to the study published, Europe and the United States has around 6 Mycosis fungoides cases per million every year. This accounts for 4% of all non-Hodgkin lymphoma cases. It is more common in adults over 50 years of age, with a male: the female ratio between 1.6 and 2.

As per the recent research report published by Fact.MR, the global Folliculotropic Mycosis Fungoides Treatment Market Sales is on course to achieve a highly eye-catching growth during 2021- 2031.

The report begins with a brief presentation and overview of the Folliculotropic Mycosis Fungoides Treatment market, about the current market landscape, trends, major Key players, product type, application, and region.

Global Folliculotropic Mycosis Fungoides Treatment Market: Market Outlook

Folliculotropic Mycosis Fungoides is a most common variant of mycosis fungoides (Alibert-Bazin), known as cutaneous T-cell lymphoma. The major symptoms of cutaneous T-cell lymphoma disease are the enlarge lymph nodes severe itching and rashes. The mycosis fungoides can be identified by the skin symptoms like plaques, acneiform lesions, or as a tumor being alopecia and pathches.

The early-stage mycosis fungoides grows very slow initially and treated with skin-directed treatment. But the advanced-stage mycosis fungoides requires more aggressive therapies. The adults aged more than 50 years are more susceptible to this disease

To get in-depth insights Request for Brochure here – https://www.factmr.com/connectus/sample?flag=B&rep_id=5653

We at Fact.MR (Leading business and competitive intelligence provider) is providing digitalization tools for gathering innovative ideas and interesting insights related to the Folliculotropic Mycosis Fungoides Treatment market trends.

Further, the Folliculotropic Mycosis Fungoides Treatment market Survey report emphasizes the adoption pattern And Demand of Folliculotropic Mycosis Fungoides Treatment across various industries.

The Sales Analysis research provides detailed information about the key segments, driving and restraining factors, geographical outlook, and the present situation of the vendor landscape of the global Folliculotropic Mycosis Fungoides Treatment market Outlook.

The Key trends Analysis of Folliculotropic Mycosis Fungoides Treatment Market also provides dynamics that are responsible for influencing the future Sales and Demand.

To gain a deep understanding of the competitive landscape in the global Folliculotropic Mycosis Fungoides Treatment market better, the Survey report covers the profile of the following top players:

Key players such as

  • Takeda Pharmaceutical Company Ltd.
  • Merck & Co. Inc.
  • Seattle Genetics, Inc.
  • Kyowa Kirin Co. Ltd.
  • Eisai Co.Ltd.
  • Helsinn Healthcare SA
  • Horizon Therapeutics plc.
  • Celegene Corporation
  • Azurity Pharmaceuticals Inc.
  • Elorac
  • Soligenix
  • Actelion pharmaceuticals Ltd.
  • Others are actively involved in folliculotropic mycosis fungoides treatment market.

What are the Key Trends Impacting Growth of the Global Folliculotropic Mycosis Fungoides Treatment Market?

The folliculotropic mycosis fungoides treatment market is brimming with emerging market and government organizations, developing to introduce innovations in the field of biotechnology and life science areas. The growing focus in research & development activities is another trending factor actively adopted by the leading manufacturers and researchers.

The new drug approvals to treat such rare diseases is another key to step towards the folliculotropic mycosis fungoides treatment that expects to serve lucrative opportunities in the folliculotropic mycosis fungoides treatment market.

For instance, in June 2020, the European Commission approved Kyowa Kirin Co., Ltd., to commercialize POTELIGEO® (mogamulizumab) in Germany for the treatment of mycosis fungoides in adults. The treatment was applicable for the patients who have already received at least one pre-systemic therapy.

POTELIGEO is the first-in-class humanised monoclonal antibody that increases the attraction of immune cells from the immune system to destroy the cancerous cells. The growing shift towards biologics from therapeutic landscape expects to boost the folliculotropic mycosis fungoides treatment market growth rapidly.

The regulatory bodies are recognizing the newly developed product under special drug designation that benefits the vendors that contribute to increasing the sales of folliculotropic mycosis fungoides drugs fueling the folliculotropic mycosis fungoides treatment market growth in the coming years.

After glancing through the report on global Folliculotropic Mycosis Fungoides Treatment market Demand, readers will get valuable insight into the following: 

  • What opportunity Trends and drivers await the market in the forthcoming years?
  • Which of the regions are likely to offer plethora of opportunities for the global Folliculotropic Mycosis Fungoides Treatment market Demand?
  • What are the emerging Sales revenue streams for the Folliculotropic Mycosis Fungoides Treatment market?
  • What are the business models and technologies with disruptive potential?
  • Precise Year-on-Year growth of the Folliculotropic Mycosis Fungoides Treatment market Share?

The Survey report highlights the growth factors and entry barriers for the key players and talks about the new trends emerging in the global Folliculotropic Mycosis Fungoides Treatment market. In addition to this, the study sheds light on changing market size, revenue growth, and share of important product segments.

Analysts at Fact.MR give prominent data on recent technological developments and product developments in the Folliculotropic Mycosis Fungoides Treatment Demand during the assessment period.

What Strategies are the Key Players Adopting to Increase their Market Share in the Folliculotropic Mycosis Fungoides Treatment Market?

The established manufacturers are exploring opportunities in developing nations like India, China to enhance their revenue gains by highly investing in research areas to innovate progressive solutions for folliculotropic mycosis fungoides treatment market.

The companies are actively focusing on novel product development, new product launches. The leading companies are actively participating in collaborative agreements and acquisitions to increase their folliculotropic mycosis fungoides treatment market penetration and shape their position in the leading folliculotropic mycosis fungoides treatment market. Additionally, the companies are actively entering into strategic distribution agreements to expand their sales footprint worldwide

  • In January 2020, the Almirall entered into a broad research agreement by acquired Bioniz Therapeutics to further expand its innovative pipeline in medical dermatology sector.
  • In January 2018, Takeda Pharmaceutical Company Ltd. Received European Commission approval for ADCETRIS (brentuximab vedotin) for CD30-Positive Cutaneous T-Cell Lymphoma. This approval by European Commission has expanded the companies sales in 28 European member states.

Enquiry Before Buying – https://www.factmr.com/connectus/sample?flag=EB&rep_id=5653

The Sales study on the Folliculotropic Mycosis Fungoides Treatment market offers a scrutiny of the demand and consumption volumes, factors affecting these, and share and size of the various end-use segments.

The Folliculotropic Mycosis Fungoides Treatment Demand study has identified the segments that are expected to contribute major shares to the revenues.

What are the Key Opportunities in Folliculotropic Mycosis Fungoides Treatment Market?

The various pharmaceutical and the biotechnology companies are focusing on research areas to capture the unmet needs of the highly effective treatment to provide a long-term effective tratment. Concurrently, investments for increasing the production of folliculotropic mycosis fungoides products are showing increasing growth.

Key Segments of Global Folliculotropic Mycosis Fungoides Treatment Market Covered in the Report

Based on type, the global folliculotropic mycosis fungoides treatment market has been segmented as

  • Small molecule
  • Biologics

Based on drug type, the global folliculotropic mycosis fungoides treatment market has been segmented as

  • Topical Steroids
  • Antineoplastic agents
    • Mechlorethamine
    • Bexarotene
    • ingenol mebutate
    • diclofenac
  • Interferons
  • Others

Based on therapy, the global folliculotropic mycosis fungoides treatment market has been segmented as

  • Radiation Therapy
  • Photodynamic Therapy
  • Targeted Therapy
  • Chemotherapy
  • Drug Therapy
  • Immunotherapy
  • Psoralen Pus Ultraviolet A (PUVA)
  • Ultraviolet B (UVB)

Based on end users, the global folliculotropic mycosis fungoides treatment market has been segmented as

  • Hospitals
  • Speciality clinics
  • Others

Based on the region, the global folliculotropic mycosis fungoides treatment market has been segmented as

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Why the North America is Dominating Folliculotropic Mycosis Fungoides Treatment Market?

North America is dominating the folliculotropic mycosis fungoides treatment market owing to the increasing prevalence of folliculotropic mycosis fungoide among the growing geriatric population in the American countries.

The presence of major key players in North America like Pfizer Inc., Astellas, and other key players are witnessing the region to persist strong R&D background with increased healthcare expenditure. Urbanization in cities of this region has led to a rise in economic standards and changing consumer preference for self-care with increased capacity for rare disease treatment.

According to the Cutaneous Lymphoma Foundation data, in U.S every year around 3000 new cases of Cutaneous T-Cell Lymphoma patients are found.

Request Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=5653

It also includes the impact of COVID-19 on the global Folliculotropic Mycosis Fungoides Treatment market future forecasts, growth opportunities, end-user industries.

What is the Repercussion of the Covid-19 Pandemic on the Growth of the Folliculotropic Mycosis Fungoides Treatment Market?

The Covid-19 pandemic had hit the hardest areas in the weak as well as the developed region. The countrywide lockdown, restriction for migration, disruption in the supply chain had dropped down the global economic market.

The reduction in patient visits in hospitals and clinics to prevent the exposure of coronavirus infection and additional spendings anticipated short term negative impact on the folliculotropic mycosis fungoides treatment market.

The business pattern of each player has been elaborately discussed in the Folliculotropic Mycosis Fungoides Treatment Demand report. This includes innovative product launches, partnerships, mergers and acquisitions, joint ventures, and others.

Besides this, the Folliculotropic Mycosis Fungoides Treatment Market Size report also encompasses the possible threats and possible growth opportunities that the Key players may face during the forecast period.

How will be insights and estimations provided in the Fact.MR report on the Demand Of Folliculotropic Mycosis Fungoides Treatment make a difference:

  • The study takes a closer look at the major economic turmoil, with a focus on the recent COVID-19 pandemic disruptions
  • The assessment of key growth dynamics highlights the attractiveness of new automation technologies and offers readers insight on the prospect of the Folliculotropic Mycosis Fungoides Treatment market Size and shares.
  • Provides scrutiny of the Folliculotropic Mycosis Fungoides Treatment market industry trends that have shaped recent government policies
  • Provides an account of major breakthroughs in all segments that might change the Sales and size of the market considerably
  • Provides an incisive analysis of socio-political milieu in which the key markets operate, and how will that influence the lucrativeness of the overall Folliculotropic Mycosis Fungoides Treatment Market demand.
  • Analyzes how collaborations and partnerships among players from different industries shape the Folliculotropic Mycosis Fungoides Treatment market growth dynamics in the near future
  • Evaluates the role of various stages of funding on Folliculotropic Mycosis Fungoides Treatment market Sales avenues in key regional markets.

The Sales Analysis report on the Folliculotropic Mycosis Fungoides Treatment market discusses the possible outcomes of investment in certain strategies that can be adopted during the forecast period for generating revenues & Sales growth. The main objective of the Survey report Of Folliculotropic Mycosis Fungoides Treatment is to draw a basic outline of the market Outlook and describe its classification.

Note :– Get access to new avenues in the Folliculotropic Mycosis Fungoides Treatment market Sales Analysis report to take your business on high growth trajectory .

More Related Reports By Fact.MR On Healthcare Domain :

Veterinary Endodontics Market – Veterinary Endodontics market is set to witness steady growth during the year 2021-2031

Therapeutic Support Surface Market – Therapeutic Support Surface market is set to witness a 6.2% growth during the year 2021-2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner. 

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E Mail : sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Demand for Surgical Medical Lasers Is Poised to Surge at a CAGR of around 8.5% by 2031

As per a new report published by Fact.MR – a market research and competitive intelligence provider, the market for medical laser systems is poised to surge at a CAGR of around 8.5% and top US$ 7.5 Bn valuation by 2031.

Medical laser systems consist of a wide variety of monochromatic lights with a specific wavelength that have strong emissions and are highly concentrated. The characteristics of laser lights are defined by their power, wavelength, and pulsed or continuous wave operation. Laser lights are best known for laser tissue interaction: photothermal reactions, photochemical reactions, and photoablation.

To remain ‘ahead’ of your competitors, request a sample
https://www.factmr.com/connectus/sample?flag=S&rep_id=6711

“With advancements in laser technology, strides taken by photonics in the past decade, growing number of research activities, and collaborations between medical and research institutes have propelled the demand for medical laser systems,” says a Fact.MR analyst.      

Medical lasers are medical devices that use precisely focused light sources to treat or remove tissues, and are used in medical diagnosis and treatments such as photodynamic therapy, laser-assisted procedures, photomedicine, and light therapy. Medical lasers are used in a broad range of applications such as dermatology, ophthalmology, gynaecology, dentistry, and many more.

Medical lasers can be used for very precise surgical procedures due to their specific wavelength, which is focused in a narrow beam and creates a very high-intensity light. Rising demand for advanced laser-based treatments for eye disorders and increasing use of medical laser treatments for chronic diseases are major factors contributing to growth of the global medical laser systems market.

For Comprehensive Insights Ask An Analyst Here
https://www.factmr.com/connectus/sample?flag=AE&rep_id=6711

medical laser systems market by FactMR

Key Segments in Medical Laser Systems Industry Research

  • Product

    • Diode Medical Laser Systems
    • Dye Medical Laser Systems
    • Gas Medical Laser Systems
    • Solid State Medical Laser Systems

  • Application

    • Aesthetic Medical Lasers
    • Ophthalmic Medical Lasers
    • Surgical Medical Lasers
    • Dental Medical Lasers
    • Diagnostic Medical Lasers

Get Customization on this Research Report for specific research solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=6711

Key Takeaways from Market Study

  • Global medical laser systems market to top US$ 7.5 Bn by 2031.
  • Aesthetic lasers projected to reach around US$ 3.5 Bn by 2031.
  • Ophthalmic lasers projected to record around 5% CAGR over the next 10 years.
  • Market in Japan to record 4% CAGR over the forecast period of 2021- 2031.
  • China forecast to reach a projected market size above US$ 2 Bn by 2031.
  • Market in Canada projected to expand at above 6% CAGR over the next 10 years.

Market Competition

Top companies are adopting several organic and inorganic strategies to strengthen their position in the market. Most are focusing on expanding their production facilities and acquiring other businesses.

A great deal of investments is being made towards R&D projects aiming at developing innovative and advanced medical laser systems. This will further create growth opportunities for market players over the coming years.

  • In 2018, Alcon Inc. launched software and hardware enhancements to the WaveLight Refractive Suite. These new software updates enhance the graphical user interface of the Suite’s WaveNet Planning Station, EX500 Excimer Laser, and the FS200 Femtosecond Laser.

Key Companies Profiled

  • Biolase Inc.
  • Bausch & Lomb Holdings
  • Cardiogenesis Corporation, Inc.
  • Lumenis Ltd.
  • IRIDEX Corp.
  • Novadaq Technologies, Inc.
  • Photomedex, Inc.
  • Spectranetics Corporation
  • Syneron-Candela
  • Alcon Laboratories, Inc.

For More Insights https://www.biospace.com/article/canine-separation-anxiety-treatment-market-will-surpass-us-26-13-mn-by-2031-driven-by-surging-pet-adoption-fact-mr/

More Insights Available

Fact.MR, in its new offering, presents an unbiased analysis of the medical laser systems market, presenting historical demand data (2016-2020) and forecast statistics for the period of 2021-2031.

The study divulges essential insights on the market on the basis of product (diode laser systems, dye laser systems, gas laser systems, and solid state laser systems) and application (aesthetic lasers, ophthalmic lasers, surgical lasers, dental lasers, and diagnostics lasers), across seven major regions of the world (North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa).

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Categories
Pharmaceutical

Demand for Helicobacter Pylori Hospital Acquired Testing Kits Is Expected to Exhibit a CAGR of Around 15% over the Forecast Period (2021-2031)

As per Fact.MR – a market research and competitive intelligence provider, the Revenue Share of Americas hospital acquired infection testing was valued at US$ 595 Mn in 2020, and is expected to exhibit a CAGR of around 15% over the forecast period (2021-2031).

Increasing medical tourism is expected to aid the growth of emergency medicine services, including the use of ambulances, ambulatory surgical centers, and hospitals, which, in turn, will create demand for hospital acquired infection testing kits. Infants, elderly people, and people with weak immunity systems are at a greater risk of developing hospital acquired infections (HAIs). Many common antibiotics are resistant to various organisms present in hospitals. Widespread use of antibiotics in hospitals promotes the development of resistant bacteria. Urinary tract infection (UTI), surgical site infections, pneumonia, lung infections, and bacterial infections are commonly acquired hospital infections.

For More Insights Into The Market, Request a Sample of this Report –
https://www.factmr.com/connectus/sample?flag=S&rep_id=6592

“Surge in surgical procedures and government initiatives to control & create awareness regarding hospital acquired infections are anticipated to drive market growth over the coming years,” says a Fact.MR analyst.

As per the Centers of Disease Control and Prevention (CDC) estimates, in hospitals across the Americas alone, 1.7 million patients suffer from HAIs and 99,000 deaths occur every. This high mortality rate associated economic burden has compelled healthcare providers to device an effective strategy to lower infection rates.

The current COVID-19 pandemic crisis is expected to have a moderately positive impact on market growth. This can be attributed to growing number hospitalizations due to COVID-19 across the Americas. Prolonged hospital stays and frequent use of ventilators increase the chances of patients acquiring infections. Thus, as the number of hospitalizations is high, demand for HAI testing kits is expected to see a rise.

Segments as per Americas Hospital Acquired Infection Testing Industry Research

  • By Test
    • MSRA Testing Kits
      • MRSA Real-Time PCR Detection Kits
      • MRSA Rapid Test Kits
    • Staphylococcus aureus Detection Kits
      • Staphylococcus aureus Latex Test Kits
      • Staphylococcus aureus Assay Test Kits
    • Clostridium difficile Testing Kits
      • Clostridium difficile Detection Panels
      • Clostridium difficile Immunoassay Kits
    • Helicobacter pylori Testing Kits
      • Helicobacter pylori Rapid Antigen Test Kits
      • Helicobacter pylori IgG antibodies Test Kits
    • Rotavirus/ Adenovirus Real-time PCR Kits
      • RSV RT-PCR Test Kit
      • RSV Ag Rapid Test Kits
    • Strep A Rapid Testing Kits
    • Strep B Rapid Testing Kits
    • Mononucleosis Testing Kits
    • Calprotectin Test Kits
  • Modality
    • Immunoassay Testing
    • Point-of-care Testing
  • By Sample
    • Blood
    • Nasal Swabs
    • Urine
    • Stool
  • By End User
    • Hospitals
    • Diagnostic Laboratories
    • Cancer Research Institutes
    • Specialty Clinics
    • Home Care Settings

Share Your Requirements & Get Customized Reports –
https://www.factmr.com/connectus/sample?flag=RC&rep_id=6592

americas hospital acquired infection testing market modality by FactMR

Key Takeaways from Market Study

  • By test, helicobacter pylori testing kits hold around 26.4% value share of the total Americas market.
  • Based on modality, point-of-care testing is leading with 69% market share.
  • By end user, diagnostic laboratories dominate the HAI testing market with a value share of 35%, while on the other hand, home care settings are expected to increase at a higher CAGR of 23%.
  • By country, the U.S. dominates the Americas hospital acquired infection testing market with a value share of 58%.

Who is winning?

The Americas market is set to expand due to rise in incidence of hospital acquired infections. Leading industry players are set to focus on research & development as well as strategic & geographic expansion in order to strengthen their presence in the region.

  • Thermo Fisher Scientific
  • bioMérieux SA
  • Becton Dickinson & Co.
  • Abbott
  • Danaher
  • Quidel Corporation
  • BioFire Diagnostics
  • Qiagen

Get Full Access of Americas Hospital Acquired Infection Testing Market Exclusive Report
https://www.factmr.com/checkout/6592

Want more insights?

Fact.MR brings a comprehensive research report on forecasted revenue growth at the Americas, regional, and country levels, and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031.

The Americas hospital acquired infection testing market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the basis of test, modality, sample, and end user, across three main regions.

Key Questions Answered in Report

  • Which geographic regions will continue to remain most profitable markets for hospital acquired infection testing?
  • Which parameters will bring a change in the demand for hospital acquired infection testing during the forecast period?
  • How will changing trends impact the market?
  • How will the COVID-19 pandemic impact market growth?
  • How can market players capture the low-hanging opportunities in developed regions?
  • What are the winning strategies of stakeholders in the hospital acquired infection testing market to upscale their position in this landscape?
  • What are the restraints that investors need to be aware of and might tackle while investing in the market?

For More Insights https://www.biospace.com/article/tumor-lysis-syndrome-treatment-demand-fuelled-by-favorable-reimbursement-policies-says-fact-mr/

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Demand Value for Medical Liquid Oxygen Systems In the U.S Is Estimated at US$ 5 Bn Over the Next 10 Years

As per a new report published by Fact.MR – a market research and competitive intelligence provider, the market for medical oxygen systems is anticipated to top US$ 5 Bn by 2031 and expand at a CAGR of 7%.

Widespread advancements occurring in the field of healthcare and medicine are primarily responsible for driving demand for medical oxygen systems. These systems are used to treat patients who are no longer able to receive adequate volumes of oxygen through the breathing of natural air and who require higher concentrations of oxygen.

Due to the outbreak of the current COVID-19 pandemic, many people across the world are suffering with breathing difficulties on account of the severity of infection. This has surged demand for medical oxygen systems on an emergency basis. In addition, many companies are pouring in humungous investments to improve the quality of oxygen supplying equipment, consequently spiking the supply of related devices.

For More Insights Into The Market, Request a Sample of this Report –
https://www.factmr.com/connectus/sample?flag=S&rep_id=6649

“Attributable to the current pandemic and rising cases of pulmonary ailments worldwide, demand for medical oxygen systems is set to surge over the coming years,” says a Fact.MR analyst.

Key Segments Covered in Medical Oxygen Systems Industry Research

  • By Product
    • Compressed Medical Oxygen Cylinders
    • Medical Oxygen Concentrators
    • Medical Liquid Oxygen Systems
  • By Modality
    • Portable Medical Oxygen Systems
    • Stationary Medical Oxygen Systems
  • By End User
    • Medical Oxygen Systems for Hospitals
    • Medical Oxygen Systems for Emergency Medical Centres
    • Medical Oxygen Systems for Ambulatory Surgical Centres
    • Medical Oxygen Systems for Home Care Centres

Share Your Requirements & Get Customized Reports –
https://www.factmr.com/connectus/sample?flag=RC&rep_id=6649

medical oxygen systems market by FactMR

Key Takeaways from Market Study

  • Valuation of medical oxygen systems reached US$ 3 Bn in 2020, and is expected to top US$ 5 Bn by 2031.
  • Key factors driving demand for medical oxygen systems include product innovations for homecare use and rise in occurrences of respiratory disorders worldwide.
  • North America accounts for one-third of the market share for medical oxygen systems.
  • Demand for medical oxygen systems in the U.S. topped US$ 711 Mn in 2020.
  • Rising number of COVID-19 cases with breathing disorders is the main factor for the sudden upsurge in demand for medical oxygen systems in India.
  • Compressed medical oxygen cylinders account for 40% revenue share in the market.

Get Full Access of Medical Oxygen Systems Market Exclusive Report
https://www.factmr.com/checkout/6649

Winning Strategy

This market depicts the presence of a substantially competitive vendor landscape, with the presence of a handful of players exerting dominance. Regulation of trial costs, achieving geographical expansion, and bringing forth efficiency of activities undertaken are key strategies being implemented by most manufacturers of medical oxygen systems.

Several players are expected to improve their product quality, increase product differentiation, and enhance their hold on the marketplace. With increasing number of players expected to enter this space in the near future, competition is likely to further intensify in the medical oxygen systems industry.

  • Koninklijke Philips N.V
  • Inogen
  • BOC Healthcare
  • Precision Medical
  • Luxfer Group
  • Cryofab
  • Responsive Respiratory
  • Atlas Copco
  • GCE group
  • High Vacuum Maintenance (HVM) S.R.L.

Key Market Insights Covered in Medical Oxygen Systems Industry Survey:

  • Market Estimates and Forecasts (2016-2031)
  • Key Drivers and Restraints Shaping Market Growth
  • Segment-wise, Country-wise and Region-wise Analysis
  • Competition Mapping and Benchmarking
  • Market Share Analysis
  • COVID-19 Impact on Demand for Medical Oxygen Systems and How to Leverage
  • Recommendation on Key Winning Strategies

For More Insights https://www.biospace.com/article/cell-proliferation-market-players-are-relying-on-partnerships-and-alliance-to-speed-up-r-and-d-study/

Key Questions Answered in Report

  • Which are the most lucrative markets for medical oxygen systems?
  • Which factors will impact the growth of medical oxygen systems market?
  • How will changing trends impact the strategies of market players?
  • How can market players capture the low-hanging opportunities across regions?
  • Which companies are leading the medical oxygen systems industry?
  • What are the winning strategies of stakeholders in the market?

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Demand for Surgical Microscopy Cameras Is Increased Owing to Its Property of Capturing Abnormal Blood Circulation

Fact.MR – a market research and competitive intelligence provider, projects the market outlook for medical camera is having a positive outlook, expanding at a CAGR of above 8% across the 2021-2031 forecast period.

Medical cameras are used to visualize internal body parts hidden by skin & bones for clinical purposes. These cameras are used in surgeries and other healthcare applications to record techniques, which further can be utilized for training and reviewing purposes.

Medical cameras are specialized types of camera that are used for documentation of clinical demonstration of patients, medical and surgical procedures, and medical devices. These are high-resolution cameras meant for obtaining enhanced and magnified images for clear diagnosis of any kind of injury, disease, or medical anomalies.

For More Insights Into The Market, Request a Sample of this Report –
https://www.factmr.com/connectus/sample?flag=S&rep_id=6636

“Growing preference for high resolution digital images rendering excellent clarity & precision in medical & healthcare applications expected to boost demand for medical cameras,” says a Fact.MR analyst. 

Technological advancements in medical cameras have facilitated more clarity in images and accurate diagnosis, which, in turn, has driven their demand over the years.

Key Market Segments in Medical Camera Industry Research

  • Type
    • Dental Cameras
    • Dermatology Cameras
    • Endoscopy Cameras
    • Ophthalmology Cameras
    • Surgical Microscopy Cameras
  • Sensor
    • Charge Couple Devices (CCD)
    • Complementary Metal-oxide Semiconductors (CMOS)
  • Resolution
    • High Definition Medical Cameras
    • Standard Definition Medical Cameras
  • End User
    • Medical Cameras for Hospitals
    • Medical Cameras for Diagnostic Centers
    • Medical Cameras for Academic and Research Institutes
    • Medical Cameras for Ambulatory Surgery Centers

Share Your Requirements & Get Customized Reports –https://www.factmr.com/connectus/sample?flag=RC&rep_id=6636

medical camera market by FactMR

Key Takeaways from Market Study

  • Global medical camera market to top US$ 2 Bn by 2031.
  • Endoscopy segment projected to reach around US$ 1.5 Bn by 2031.
  • Dermatology segment projected to record around 5% CAGR over the next 10 years.
  • Market in Japan to record 4% CAGR over the forecast period of 2021- 2031.
  • China to reach projected market size above US$ 1.1 Bn by the year 2031.
  • Market in Canada projected to expand at above 5% CAGR over the next 10 years.

Market Competition

Companies leverage strategic collaborative initiatives to increase their market share and profitability. Companies operating in the market are also acquiring start-ups working to strengthen their product capabilities.

  • In 2017, scientists at the University of Edinburgh, Scotland, developed a medical camera that can see through the human body. These cameras are developed to track down endoscopy devices for the investigation of internal conditions.
  • In 2018, karlStroz launched a 4mm Endoscopic NIR/ICG Fluorescence Imaging System, enhancing minimally invasive neurosurgery.
  • In 2019, Olympus launched a small intestine endoscopy system, ‘Power Spiral’, in Asia, including Hong Kong and India, and also in Europe.
  • Olympus Corporation
  • Sony Corporation
  • Basler AG
  • IMPERX, Inc.
  • Optomed Plc
  • IDS Imaging Development Systems GmbH
  • Danaher
  • Carestream Health, Inc.
  • Stryker Corporation
  • Richard Wolf GmbH
  • Smith & Nephew PLC
  • Leica Microsystems

Get Full Access of this Exclusive Report
https://www.factmr.com/checkout/6636

More Insights Available

Fact.MR, in its new offering, presents an unbiased analysis of the medical camera market, presenting historical demand data (2016-2020) and forecast statistics for the period of 2021-2031.

The study divulges essential insights on the market on the basis of type (dental cameras, dermatology cameras, endoscopy cameras, ophthalmology cameras, and surgical microscopy cameras), sensor (charge couple devices (CCD) and complementary metal-oxide semiconductors (CMOS)), resolution (high definition cameras and standard definition cameras), and end user, (hospitals, diagnostic centers, and academic & research institutes, ambulatory surgery centers), across seven major regions of the world (North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa).

Key Insights Offered in Medical Camera Industry Survey:

  • Market Estimates and Forecasts (2016-2031)
  • Key Drivers and Restraints Shaping Market Growth
  • Segment-wise, Country-wise, and Region-wise Analysis
  • Competition Mapping and Benchmarking
  • Brand Share and Market Share Analysis
  • Key Product Innovations and Regulatory Climate
  • COVID-19 Impact on Medical Camera Sales and How to Navigate
  • Recommendation on Key Winning Strategies

For More Insights
https://www.biospace.com/article/increment-in-abdominal-organ-donors-is-having-substantial-influence-of-development-of-surgical-hand-access-port-market-finds-fact-mr/

Key Questions Answered in Report

  • Which are the most lucrative markets for medical camera?
  • Which factors will impact the growth of the market?
  • How will changing trends impact the strategies of market players?
  • How can market players capture the low-hanging opportunities across regions?
  • Which companies are leading the medical camera market?
  • What are the winning strategies of stakeholders in the market?

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Revenue Share of Electrical Variants of Self-Care Medical Devices is Anticipated to Top US$ 20 Bn by 2031

As per a new report published by Fact.MR – a market research and competitive intelligence provider, the market for self-care medical devices is anticipated to top US$ 20 Bn by 2031, and is poised to expand at a CAGR of 6%. Demand for blood glucose monitors accounts for 58% of overall market share.

Rise in the prevalence of various chronic diseases has led to the growth of the global self-care medical devices market. These devices assist in better patient compliance and improvement in disease management.

Recent entry of top-notch technologies has made the invention of a smart tract with real-time health monitoring feature a reality. In addition, rising awareness among people regarding these devices will further propel demand for self-care medical devices in the years to come.

“With rising preference for homecare treatments by patients, demand for self-care medical devices is set to propel over the coming years,” Says a Fact.MR analyst.

For More Insights Into The Market, Request a Sample of this Report –
https://www.factmr.com/connectus/sample?flag=S&rep_id=6629

Augmented knowledge of one’s condition of health and advantages pertaining to the use of medical gadgets such as glucose monitors and insulin pumps is further likely to pave way for the growth of the global self-care medical devices market over the years.

Key Segments Covered in Self-care Medical Devices Industry Research

  • By Product
    • Self-monitoring of Blood Glucose
    • Sleep Apnea Devices
    • Insulin Pumps
    • Body Temperature Monitors
    • Inhalers
    • Pedometers
    • Blood Pressure Monitors
    • Nebulizers
    • Male External Catheters
    • Holter Monitors
  • By End User
    • Self-care Medical Devices for Geriatrics
    • Self-care Medical Devices for Pediatrics
    • Self-care Medical Devices for Adults
    • Self-care Medical Devices for Pregnant Women
  • By Distribution Channel
    • Self-care Medical Devices Sold at Pharmacies
    • Self-care Medical Devices Sold through Online Stores
    • Self-care Medical Devices Sold at Supermarkets and Hypermarkets

Share Your Requirements & Get Customized Reports –
https://www.factmr.com/connectus/sample?flag=RC&rep_id=6629

self care medical devices market by FactMR

Key Takeaways from Market Study

  • Valuation of self-care medical devices was estimated at US$ 13 Bn in 2020, and is expected to top US$ 20 Bn by 2031.
  • Key factors driving demand for self-care medical devices include new technological advancements and rising demand for homecare treatments.
  • North America holds close to 40% of the market share for self-care medical devices.
  • In China, demand for self-care medical devices was estimated at US$ 4 Bn in 2020, and is anticipated to expand at a CAGR of 9% over the coming ten years.
  • Demand for blood glucose monitors accounts for 58% of market share for self-care medical devices.
  • Global demand for blood pressure monitors is anticipated to reach a valuation of around US$ 3 Bn by 2031-end.

Get Full Access of this Exclusive Report
https://www.factmr.com/checkout/6629

Winning Strategy

Major players in the market are adopting strategies such as launching new products to expand their product portfolios and investing in new R&D projects aimed towards product innovation.

Many manufacturers are working towards making portable and easy-to-use devices.  New and upcoming companies can direct their focus towards product innovation and carrying out awareness campaigns for better reach and costumer acquisition.

  • Johnson & Johnson
  • Medtronic
  • Abbott Laboratories
  • Bayer HealthCare
  • Koninklijke Philips
  • General Electric Company
  • F. Hoffmann-La Roche AG
  • ResMed
  • Omron Healthcare
  • Martifarm
  • OraSure Technologies

Find More Valuable Insights

Fact.MR, in its new offering, presents an unbiased analysis of the self-care medical devices market, presenting historical market data (2016-2020) and forecast statistics for the period of 2021-2031.

The study reveals essential insights on the basis of product (self-monitoring of blood glucose, sleep apnea devices, insulin pumps, body temperature monitors, inhalers, pedometers, blood pressure monitors, nebulizers, male external catheters, and holter monitors), end user (geriatric, pediatrics, adults, and pregnant women), and distribution channel (pharmacies, online stores, and supermarkets & hypermarkets), across major regions of the world (North America, Europe, Asia Pacific, Central & South America, and the Middle East & Africa).

Key Points Covered in Self-care Medical Devices Industry Survey:

  • Market Estimates and Forecasts (2016-2031)
  • Key Drivers and Restraints Shaping Market Growth
  • Segment-wise, Country-wise and Region-wise Analysis
  • Competition Mapping and Benchmarking
  • Market Share Analysis
  • COVID-19 Impact on Sales of Self-care Medical Devices and How to Navigate
  • Recommendation on Key Winning Strategies

For More Insights  https://www.biospace.com/article/bone-marrow-processing-systems-growth-driven-by-progressions-in-bone-marrow-needles-and-harvest-technology-says-fact-mr/

Key Questions Answered in Report

  • Which are the most lucrative markets for self-care medical devices?
  • Which factors will impact the demand for self-care medical devices?
  • How will changing trends impact the strategies of market players?
  • How can market players capture the low-hanging opportunities across regions?
  • Which companies are leading the self-care medical devices industry?
  • What are the winning strategies of stakeholders in the market?

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Surging Lung Cancer Incidence Rates Spurring Biomarkers Demand for Colorectal Cancer Biomarkers – Fact.MR Study

According to Fact MR’s recent market research, sales of Colorectal Cancer Biomarkers to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Focus on improving overall patient care will remain a chief growth driver. Besides this, Colorectal Cancer Biomarkers market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To remain ‘ahead’ of your competitors, request for a sample –   https://www.factmr.com/connectus/sample?flag=S&rep_id=4587

To offer an in-depth overview, the report provides sales projections for over 20 countries. It also identifies segments exhibiting maximum growth.

Digital Transformation in Healthcare Presenting Opportunities for Colorectal Cancer Biomarkers Market Growth

Healthcare organizations around the world are deploying digital tools to accommodating changing consumer preferences. They are pressing on solving the long-standing challenge pertaining to care model innovation.

Considering this, the focus on making healthcare affordable and more transparent will increase. Adoption of care model innovation in healthcare will have a profound impact on the Colorectal Cancer Biomarkers market.

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Colorectal Cancer Biomarkers market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Colorectal Cancer Biomarkers

The report offers actionable and valuable market insights of Colorectal Cancer Biomarkers. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Colorectal Cancer Biomarkers Market across various industries and regions.

This newly published and insightful report sheds light on Market Insights of Colorectal Cancer Biomarkers, key dynamics, their impact on the overall value chain from suppliers to end-users and Growth of Colorectal Cancer Biomarkers Market.

Key Segments Covered

  • Test Type

    • PSA Cancer Biomarker Tests
    • CTC Cancer Biomarker Tests
    • AFP Cancer Biomarker Tests
    • CA Cancer Biomarker Tests
    • HER2 Cancer Biomarker Tests
    • BRCA Cancer Biomarker Tests
    • ALK Cancer Biomarker Tests
    • CEA Cancer Biomarker Tests
    • EFGR Mutation Cancer Biomarker Tests
    • KRAS Mutation Cancer Biomarker Tests
    • Other Cancer Biomarker Tests

  • Illness Indication

    • Blood Cancer Biomarkers
    • Prostate Cancer Biomarkers
    • Ovarian Cancer Biomarkers
    • Stomach Cancer Biomarkers
    • Liver Cancer Biomarkers
    • Other Cancer Biomarkers

Need more information about Report Methodology? Click here-  https://www.factmr.com/connectus/sample?flag=RM&rep_id=4587

Cancer Biomarkers Market- Scope of Report

A recent study by Fact.MR on the cancer biomarkers market offers a 10-year forecast for 2021 to 2031. The study analyzes crucial trends that are currently determining the growth of the market. This report explicates on vital dynamics, such as the drivers, restraints, and opportunities for key market players along with key stakeholders as well as emerging players associated with offering cancer biomarkers.

The study also provides the dynamics responsible for influencing the future status of the cancer biomarkers market over the forecast period. A detailed assessment of value chain analysis, business execution, and supply chain analysis across regional markets has been covered in the report. A list of prominent companies operating in the cancer biomarkers market, along with their product portfolios, enhances the reliability of this comprehensive research study.

Report Summary

The study offers comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales of Cancer biomarkers across the globe.

A comprehensive estimate on the market has been provided through an optimistic as well as a conservative scenario, taking into account the sales of cancer biomarkers during the forecast period. Price point comparison by region with global average price is also considered in the study.

Analysis on Market Size Evaluation

The market has been analyzed for each segment in terms of volume (‘000 Units) and value (US$ Mn).

Estimates at global and regional levels for cancer biomarkers are available in terms of “US$ Mn” for value and in “‘000 Units” for volume. A Y-o-Y growth contrast on prominent market segments, along with market attractiveness evaluation, has been incorporated in the report. Furthermore, absolute dollar opportunity analysis of all the segments adds prominence to the report. Absolute dollar opportunity plays a crucial role in assessing the level of opportunity that a manufacturer/distributor can look to achieve, along with identifying potential resources, considering the sales and distribution perspective in the global cancer biomarkers market.

Inspected Assessment on Regional Segments

Key sections have been elaborated in the report, which have helped deliver projections on regional markets. These chapters include regional macros (political, economic, and business environment outlook), which are expected to have a momentous influence on the growth of the cancer biomarkers during the forecast period.

Country-specific valuation on demand for cancer biomarkers has been offered for each region, along with market scope estimates and forecasts, price index, and impact analysis of the dynamics of prominence in regions and countries. For all regional markets, Y-o-Y growth estimates have also been incorporated in the report.

Detailed breakup in terms of value & volume for emerging countries has also been included in the report.

In-depth Analysis on Competition Analysis

The report sheds light on leading manufacturers of cancer biomarkers, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in offering cancer biomarkers has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which include essentials such as product portfolios and key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting the market status, and predicting the competition level in the cancer biomarkers domain.

Key Takeaways of Global Cancer Biomarkers Market Study

  • Based on test type, the Circulating Tumor Test (CTC) segment is expected to hold the maximum market share (34.7%) during the forecast period. This is followed by the Prostate Specific Antigen (PSA) test, pegged at 22.7%.
  • Lung Cancer is the most common type of disease, owing to higher incidence of cigarette smoking. The segment accounts for one-fourth of the total market share. However, breast cancer is becoming equally prevalent. This is attributed to increased life expectancy, rapid urbanization and sedentary lifestyles.
  • North America is set to remain the most lucrative market for cancer biomarkers, due to increased access to healthcare. It is expected to account for more then 2/5th market share, registering an absolute $ opportunity of US$ 5.2 Bn between 2020 and 2025.
  • However, Asia-Pacific is buckling up, owing to increased incidences of cancers in emerging economies. Projected CAGR for Asia-Pacific is estimated at 13.8% during the forecast period.

“The global cancer biomarkers market possesses immense potential for future growth, driven primarily by increased prevalence of cancer and the subsequent investment in its research and development. Favorable government policies, in terms of extending grants, has facilitated path-breaking innovations in the treatment and prognosis of cancers,” concludes a Fact.MR analyst.

Full Access of this Exclusive Report is Available at-  https://www.factmr.com/checkout/4587

Report Benefits & Key Questions Answered

  • Colorectal Cancer Biomarkers Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Colorectal Cancer Biomarkers Historical volume analysis: The report provides a comparison of Colorectal Cancer Biomarkers’s historical sales and projected sales performance for 2021-2031.
  • Colorectal Cancer Biomarkers Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Colorectal Cancer Biomarkers market. It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Colorectal Cancer Biomarkers Consumption by demographics: The report investigates consumer behavior affecting Colorectal Cancer Biomarkers demand outlook for the assessment period. Effect of their keenness for digital trends on Colorectal Cancer Biomarkers market is carefully analyzed
  • Post COVID consumer spending on Colorectal Cancer Biomarkers: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Colorectal Cancer Biomarkers market growth.

More Valuable Insights on Colorectal Cancer Biomarkers Market

Fact.MR, in its new report, offers an unbiased Market Analysis of Colorectal Cancer Biomarkers, Sales and Demand of Colorectal Cancer Biomarkers, analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Emergence of Home Care Services Influencing Market Demand for Surgical Drapes – Fact.MR Study

According to Fact MR’s recent market research, sales of Surgical Drapes to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Focus on improving overall patient care will remain a chief growth driver. Besides this, Surgical Drapes market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

To remain ‘ahead’ of your competitors, request for a sample –  https://www.factmr.com/connectus/sample?flag=S&rep_id=4553

Digital Transformation in Healthcare Presenting Opportunities for Surgical Drapes Market Growth

Healthcare organizations around the world are deploying digital tools to accommodating changing consumer preferences. They are pressing on solving the long-standing challenge pertaining to care model innovation.

Considering this, the focus on making healthcare affordable and more transparent will increase. Adoption of care model innovation in healthcare will have a profound impact on the Surgical Drapes market.

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Surgical Drapes market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Surgical Drapes

The report offers actionable and valuable market insights of Surgical Drapes. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Surgical Drapes Market across various industries and regions.

This newly published and insightful report sheds light on Market Insights of Surgical Drapes, key dynamics, their impact on the overall value chain from suppliers to end-users and Growth of Surgical Drapes Market.

Rising prevalence of hospital-acquired infections is increasing the utilization of sterile and disposable products such as surgical gloves, surgical drapes, and surgical packs in hospitals. This is anticipated to boost the revenue growth of the global hospital supplies market. According to WHO, 15% of patients in hospitals suffer from hospital-acquired viral, bacterial, and fungal infections. Various governments and medical professionals are focusing on maintenance of safety & hygiene in hospitals, which is expected to increase the demand for hospital supplies. The global hospital supplies market was estimated to be valued at US$ 17.0 Bn in 2018 and will hurtle towards the US$21Bn mark by the end of the forecast period (2019-2029).

Need more information about Report Methodology? Click here-  https://www.factmr.com/connectus/sample?flag=RM&rep_id=4553

Key Takeaways of Global Hospital Supplies Market Study

  • By product type, surgical packs accounted for prominent value share in the global hospital supplies market. This is primarily attributed to growing need for surgical packs in various surgeries performed in hospitals and ambulatory surgical centers, globally.
  • North America and Europe will collectively hold 70% of the global hospital supplies market share. East Asia and South Asia are anticipated to exhibit notable CAGR, owing to growing hospital supplies manufacturing facilities in these regions.
  • The hospitals segment under end user dominated the global hospital supplies market, attributed to high healthcare infrastructure and large patient pool visiting hospitals.

 “Increasing investments and acquisitions by large players to expand their regional presence of sterile medical supplies is anticipated to favor the global hospital supplies market growth.” says the Fact.MR Analyst.

Acquisitions and Expansions to be Key Imperative Followed by Market Players

Sterile hospital supplies manufacturers are focusing on mergers and acquisitions, which can aid them with a broad spectrum of product offerings, enhanced capabilities, and large scale manufacturing. In 2018, Boston Scientific announced nine acquisitions and several new strategic investments totaling $6 Billion. With the growing investment for infrastructural and technological advancements, manufacturers are also focusing on inking deals with various healthcare institutions.

Key Segments of Global Hospital Supplies Market

Fact.MR’s study on the global hospital supplies market offers information divided into three important segments-product type, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Product Type

  • Surgical Gowns
    • Disposable Gowns
    • Reusable Gowns
  • Surgical Drapes
    • Disposable Drapes
    • Reusable Drapes
  • Surgical Gloves
    • Disposable Gloves
    • Reusable Gloves
  • Surgical Packs
  • Feeding Tubes

End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Full Access of this Exclusive Report is Available at-   https://www.factmr.com/checkout/4553

Report Benefits & Key Questions Answered

  • Surgical Drapes Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Surgical Drapes Historical volume analysis: The report provides a comparison of Surgical Drapes’s historical sales and projected sales performance for 2021-2031.
  • Surgical Drapes Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Surgical Drapes market. It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Surgical Drapes Consumption by demographics: The report investigates consumer behavior affecting Surgical Drapes demand outlook for the assessment period. Effect of their keenness for digital trends on Surgical Drapes market is carefully analyzed
  • Post COVID consumer spending on Surgical Drapes: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Surgical Drapes market growth.

More Valuable Insights on Surgical Drapes Market

Fact.MR, in its new report, offers an unbiased Market Analysis of Surgical Drapes, Sales and Demand of Surgical Drapes, analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Need for Enhanced Precision & Accuracy for Blood Collection Techniques Boost Demand for Blood Collection Tubes for Liquid Biopsy

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Blood Collection Tubes for Liquid Biopsy market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Blood Collection Tubes for Liquid Biopsy

This newly published and insightful report sheds light on Market Insights of Blood Collection Tubes for Liquid Biopsy, key dynamics, their impact on the overall value chain from suppliers to end-users and Growth of Blood Collection Tubes for Liquid Biopsy Market.

To remain ‘ahead’ of your competitors, request for a sample – https://www.factmr.com/connectus/sample?flag=S&rep_id=4495

The report offers actionable and valuable market insights of Blood Collection Tubes for Liquid Biopsy. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Blood Collection Tubes for Liquid Biopsy Market across various industries and regions.

Surpassing revenues worth US$ 215 Mn in 2019, sales of blood collection tubes for liquid biopsy are poised to see a healthy growth outlook at 6% CAGR during 2019 – 2029. Despite being an essential diagnostic product in the practice of laboratory biopsy testing, the blood collection tubes for liquid biopsy market is still young, and the application scope remains majorly limited to research industry.

High product availability is limited to developed regions such as North America, Europe, and Oceania. However, increased application of blood collection tubes for liquid biopsy in genetic diagnostics and other common diagnostic procedures is likely to bolster demand for blood collection tubes for liquid biopsy in following years.

The healthcare industry is consistently witnessing an increase in the number of biopsy procedures every year, globally, due to the increasing prevalence of cancer. Growing awareness and rise in cancer screening procedures has led to the growth of the blood collection tubes for liquid biopsy market which in turn has increased the rate of early diagnosis of cancer.

Key Takeaways – Blood Collection Tubes for Liquid Biopsy

  • Healthcare centers would show remarkable growth in adoption of blood collection tubes for liquid biopsy owing to the rise in number of research activities.
  • Increasing prevalence of cancers will remain one of the major factors responsible for the growth of the blood collection tubes for liquid biopsy market.
  • Blood collection tubes for liquid biopsy market is a fragmented landscape.
  • Growing demand for single needle penetration for multiple tests is identified as the key growth engine, pushing adoption of blood collection tubes for liquid biopsy.

Need more information about Report Methodology? Click here-  https://www.factmr.com/connectus/sample?flag=RM&rep_id=4495

Plastic Tubes Remain Highly Sought-after

On back of higher safety standards, Blood Collection Tubes for Liquid Biopsy will continue to gather preference over their glass counterparts. The former remains preferred for their greater reliability during routine clinical chemistry analysis, tumor screening, biopsy tests and chemotherapeutic drug monitoring. The shatter-resistant plastic further reduces the risk of exposure to pathogens and contamination.

Attractiveness of Asian Markets Intact

Growth opportunities for the blood collection tubes for liquid biopsy market players is picking up the pace in the East and South Asian regions. Increasing availability of economically affordable blood collection tubes would also be a significant booster to market growth. A large number of local manufacturers, particularly in China, Japan, and India, are increasing the scope for manufacturers and boosting the blood collection tubes for liquid biopsy market growth.

Know More About Blood Collection Tubes for Liquid Biopsy Market

Fact.MR’s business intelligence also underlines groundbreaking insights into the competitive scenario of the blood collection tubes for liquid biopsy market, along with highlights of manufacturers’ differential strategies. The blood collection tubes for liquid biopsy market is majorly covered by the players offering conventional blood collection tubes for liquid biopsy. The key players’ operating in the blood collection tubes for liquid biopsy market will continue to focus on delivering of their products through direct sales and distribution channels.

Key Segments of the Blood Collection Tubes for Liquid Biopsy Market

Fact.MR’s study on the blood collection tubes for liquid biopsy market offers information divided into four important segments-product, application, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Products ·         Plastic 

·         Glass
Application ·         IVD 

·         Research Use
End User ·         Healthcare Centers 

·         R&D Centers

·         Diagnostic Centers
Region ·         North America 

·         Latin America

·         Europe

·         East Asia

·         South Asia

·         Oceania

·         Middle East and Africa (MEA)

Full Access of this Exclusive Report is Available at-  https://www.factmr.com/checkout/4495

blood collection tubes for liquid biopsy market region by FactMR
Key Question answered in the survey of Blood Collection Tubes for Liquid Biopsy market report:

  • Sales and Demand of Blood Collection Tubes for Liquid Biopsy
  • Growth of Blood Collection Tubes for Liquid Biopsy Market
  • Market Analysis of Blood Collection Tubes for Liquid Biopsy
  • Market Insights of Blood Collection Tubes for Liquid Biopsy
  • Key Drivers Impacting the Blood Collection Tubes for Liquid Biopsy market
  • Which are the Key drivers impacted by Blood Collection Tubes for Liquid Biopsy market
  • Restraints Shaping Market Growth
  • Market Survey of Blood Collection Tubes for Liquid Biopsy

More Valuable Insights on Blood Collection Tubes for Liquid Biopsy Market

Fact.MR, in its new report, offers an unbiased Market Analysis of Blood Collection Tubes for Liquid Biopsy, Sales and Demand of Blood Collection Tubes for Liquid Biopsy, analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Increasing Adoption of Vaccines to Propel Bioengineered Cancer Drugs Market Growth by 2031 End

According to Fact MR’s recent market research, Bioengineered Cancer Drugs sales to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

The report offers actionable and valuable market insights of Bioengineered Cancer Drugs. The latest report by Fact.MR provides details on the present scenario of the market across various regions along with the historic data and forecast of the market. The report also includes information on the sales and demand of Bioengineered Cancer Drugs Market across various industries and regions.

To remain ‘ahead’ of your competitors, request for a sample –  https://www.factmr.com/connectus/sample?flag=S&rep_id=4440

Focus on improving overall patient care will remain a chief growth driver. Besides this, Bioengineered Cancer Drugs market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

Digital Transformation in Healthcare Presenting Opportunities for Bioengineered Cancer Drugs Market Growth

Healthcare organizations around the world are deploying digital tools to accommodating changing consumer preferences. They are pressing on solving the long-standing challenge pertaining to care model innovation.

Considering this, the focus on making healthcare affordable and more transparent will increase. Adoption of care model innovation in healthcare will have a profound impact on the Bioengineered Cancer Drugs market.

The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Bioengineered Cancer Drugs market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key market players as well as emerging players associated with the production and supply. The latest report by Fact.MR provides detailed Market Analysis of Bioengineered Cancer Drugs

This newly published and insightful report sheds light on Market Insights of Bioengineered Cancer Drugs, key dynamics, their impact on the overall value chain from suppliers to end-users and Growth of Bioengineered Cancer Drugs Market.

Pharmaceutical and biotechnological companies are the leading end users in the bioengineered protein drugs market, as these companies constantly strive to increase the exclusivity to their portfolios. Collectively, these end users are projected to account for 53% of the market share by 2025. However, a shift from in-house R&D towards outsourced services is augmenting the importance of contract research organisations as end users in the bioengineered protein drugs market.

Increasing reliance on these organisations for drug discovery portends the growing adoption of bioengineered protein drugs to further improve their efficacy. In addition, governments of developed regions have extended financial aid to reduce the mortality rate, which is further likely to strengthen the pathway for the penetration of bioengineered protein drugs. Though the overall market movement looks prodigious, an analytical study published by Fact.MR foresees the advent of generic drugs as an impeder to the growth of the global bioengineered protein drugs market.

Need more information about Report Methodology? Click here-   https://www.factmr.com/connectus/sample?flag=RM&rep_id=4440

Key Highlights of Bioengineered Protein Drugs Market

  • Patients suffering from cancer continue to remain the target audience of players in the bioengineered protein drugs market. Adoption of bioengineered protein drugs for treatment is projected to increase at a CAGR of around 7% during the forecast period (2020-2025). Also, a spurt in the sales of these drugs is expected, which is likely to be driven by individuals diagnosed with infectious diseases.
  • High costs associated with bioengineered protein drugs, in tandem with their short shelf life, causes reluctance among patients towards their adoption. In addition, increasing development of biosimilar products that cost just 20% of branded drugs is expected to deter revenue potential of the bioengineered protein drugs market during the forecast period.
  • Preference for oral route of drug administration for any medication is high among patients, on the back of convenience and ease. However, bioengineered protein drugs are difficult to administer in an oral formulation, on account of gastric acid formed in the stomach, which could impede their adoption rate.

A subject matter expert at Fact.MR opines,

“The healthcare industry is experiencing a shift from curative care towards preventive care, which is projected to create more sales prospects for bioengineered protein vaccines over therapeutic proteins.”

Prominent Players Rely on Generic Drugs and Strong Distribution Network

F.Hoffmann-La Roche, AbbVie, and Johnson & Johnson are the leading players, collectively accounting for around 60% share in the global bioengineered protein drugs market. The focal point of these players is on the development of branded drugs to treat myriad rare diseases. A substantial revenue of F.Hoffmann-La Roche is attributable to its blockbuster drugs – Avastin, Rituxan, and Herceptin, specifically developed for the treatment of cancer. Another leading player, AbbVie, holds a dominant position in the bioengineered protein drugs market, on account of its flagship product-Humira-which is considered as a breakthrough product to treat a number of conditions and diseases.

In contrast to the focus of leading players on the development of branded drugs, prominent and emerging players strive to ace the market race through generic formulations. Also, they take measured actions towards strengthening their distribution network to increase the accessibility of their products.

Bioengineered Protein Drugs Market – Assessment of Key Segments

Authors of this comprehensive study have classified the market into key segments for an in-depth study of the bioengineered protein drugs market. Categorisation of the bioengineered protein drugs market is based on drug type, disease, end user, and region.

This detailed study also offers information about the incremental opportunity present in the bioengineered protein drugs market during the forecast period. Key segments considered while studying the bioengineered protein drugs market include:

Drug Type
  • Therapeutic Proteins
  • Monoclonal Antibodies
  • Vaccines
Disease
  • Cancer
  • Diabetes
  • Autoimmune Disorder
  • Infectious Diseases
  • Haematopoiesis
  • CVD
  • Neurodegenerative Diseases
  • Others
End User
  • Pharmaceutical and Biotechnology Companies
  • CROs Research Institutes
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Full Access of this Exclusive Report is Available at-  https://www.factmr.com/checkout/4440

assessment of bioengineered protein drugs market by disease

Report Benefits & Key Questions Answered

  • Bioengineered Cancer Drugs Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Bioengineered Cancer Drugs Historical volume analysis: The report provides a comparison of Bioengineered Cancer Drugs’s historical sales and projected sales performance for 2021-2031.
  • Bioengineered Cancer Drugs Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Bioengineered Cancer Drugs market. It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Bioengineered Cancer Drugs Consumption by demographics: The report investigates consumer behavior affecting Bioengineered Cancer Drugs demand outlook for the assessment period. Effect of their keenness for digital trends on Bioengineered Cancer Drugs market is carefully analyzed
  • Post COVID consumer spending on Bioengineered Cancer Drugs: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Bioengineered Cancer Drugs market growth.

More Valuable Insights on Bioengineered Cancer Drugs Market

Fact.MR, in its new report, offers an unbiased Market Analysis of Bioengineered Cancer Drugs, Sales and Demand of Bioengineered Cancer Drugs, analyzing forecast statistics through 2019 and beyond. The study reveals growth projections on the basis of various criteria.

Explore Fact.MR’s Comprehensive Coverage on Healthcare Domain:

Fluoro Enzymatic Assays Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Shower Chairs Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

Infrared Thermometer Market – Global Industry Analysis and Opportunity Assessment 2021 – 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.


Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com